Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.
about
Epithelial cell dissemination and readhesion: analysis of factors contributing to metastasis formation in breast cancerCirculating tumor cells: approaches to isolation and characterizationQuantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoringSeeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cellsBlood-based analyses of cancer: circulating tumor cells and circulating tumor DNAAnalysis of Her2/neu membrane protein clusters in different types of breast cancer cells using localization microscopyClinical relevance and current challenges of research on disseminating tumor cells in cancer patientsHER2-positive circulating tumor cells in breast cancerDisseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progressionCTC enumeration and characterization: moving toward personalized medicine.Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy.The systematic study of circulating tumor cell isolation using lithographic microfiltersQuantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinomaCirculating tumor cells measurements in hepatocellular carcinoma.Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor.The prognostic implications of circulating tumor cells in patients with breast cancer.Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer.The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer.Circulating tumor cells in gastrointestinal cancer.Circulating cancer cells.Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.Circulating tumor cells as emerging tumor biomarkers in breast cancer.Nanobiotechnology for the capture and manipulation of circulating tumor cells.Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology.The role of circulating tumor cells in breast cancer diagnosis and prediction of therapy response.Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.Enrichment, detection and clinical significance of circulating tumor cells.Circulating tumor cells: utopia or reality?Circulating tumour cells-monitoring treatment response in prostate cancer.Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.Tracking metastatic breast cancer: the future of biology in biosensors.Pathway of peritoneal carcinomatosis maybe hematogenous metastasis rather than peritoneal seeding.Isolation of viable cancer cells in antibody-functionalized microfluidic devices.Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer.Clinical utility of circulating tumor cell measurement in the diagnosis of indeterminate lesions of the pancreas.
P2860
Q24606925-B2097A84-6C29-426D-A844-E61E430A5A23Q24631347-9630A2AF-7347-4DD5-81F9-AF7B0AC28D38Q25257743-7FBD0552-33F7-4D15-8B5D-41C222D1C38EQ27497448-7F36FBA0-98A5-46E6-93F3-E71EFBECE3BCQ28239638-F929A128-5522-4052-ABBF-1EF7193C72D2Q28299542-9D805728-BD34-4412-90C8-997DCA885F2CQ33555492-B209EC90-840F-4ABA-81E4-7C196188FC45Q33802925-542681F4-3206-4BE6-9DE3-3B917CA665DCQ34485079-66871078-C87C-449F-9323-D8FAAF324933Q34496964-32E9E387-4167-470A-A224-A771A3B1F31EQ34577724-1F95AC6C-CAC1-4FE1-BAFF-EE8566CC46BBQ34590296-5B587ABC-8B89-4333-8730-39DB849756C5Q34779138-65539223-B4DA-400C-8EB7-5A9FFDA8161CQ34987281-1E9C5358-2A09-4CCE-982B-9C33D29C4559Q35063733-ECB00B0C-CF17-4780-9349-A77BC683D354Q35161280-E318D8CE-A2BD-411C-B915-DAE68FB79F1BQ36011412-A163E63E-16B2-4C4D-B36A-07042AFA79CDQ36071446-1C7132C6-177D-43C6-ADB7-F3BEEEE2FE8CQ36413487-269055D8-5EC4-4A67-A9F8-6BE9033A2CFDQ36853759-189E355C-D68B-42D1-9731-05232F79609EQ37079905-C3172E9E-06B1-4902-B8D0-0826B7F586DEQ37112805-A1FDA352-5773-441E-A40B-1C876289B34BQ37565410-05673BB1-E18D-4CF9-946B-AF04C820C1B4Q37610814-908739C6-5A1F-4F9B-A19B-BBA01E9AFF0BQ37799957-F80D30B4-F8D7-4310-872E-498AAEBC9706Q37894736-839A4058-A450-4EFC-B2B2-929C02E7B510Q37908134-1E12A107-13CB-41C6-A06C-1088776298B3Q37967661-C8A739F6-A1CF-4386-BD37-A1DD75F45028Q38085411-CA15099C-86DA-42CE-BEEB-A052051BDAEEQ38089744-2DCCA42D-637E-4CBE-B639-908926339D5CQ38097525-6F6D1AF2-FC23-43A3-BBA1-0D1247DBE87CQ38102590-04561D7C-4E8D-47BE-BE06-F256270E3366Q38131799-03EE03E3-1644-4FEE-B6B2-E658A5244B53Q38211361-B4E017E4-45F9-4DC3-A681-AB2E05C1B3BDQ38547813-2FDAA329-5D9D-4111-9376-742E48A03B63Q38781796-A0A2853B-97CA-43AC-9410-EE90EF1714C2Q39014295-58E7B9EC-AF7F-48AD-8CD2-F8E948AB0252Q39182108-33861476-56F9-4C3C-B804-1F8878B67ACDQ39783158-0EA6CF3D-6154-4946-8E63-1AF385FBA1C8Q39917925-0F9B047B-A278-4C11-B0B7-BF2390B82C67
P2860
Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Standardized quantification of ...... s from lung and breast cancer.
@ast
Standardized quantification of ...... s from lung and breast cancer.
@en
type
label
Standardized quantification of ...... s from lung and breast cancer.
@ast
Standardized quantification of ...... s from lung and breast cancer.
@en
prefLabel
Standardized quantification of ...... s from lung and breast cancer.
@ast
Standardized quantification of ...... s from lung and breast cancer.
@en
P2093
P2860
P356
P1476
Standardized quantification of ...... ls from lung and breast cancer
@en
P2093
Babette Willen
Claus-Peter Schneider
Katharina Pachmann
Klaus Höffken
Oumar Camara
Ulrich Pachmann
P2860
P304
P356
10.1515/CCLM.2005.107
P577
2005-01-01T00:00:00Z